Detalhe da pesquisa
1.
The primary pharmacology of ceftazidime/avibactam: resistance in vitro.
J Antimicrob Chemother
; 78(3): 569-585, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36702744
2.
The primary pharmacology of ceftazidime/avibactam: microbiology from clinical studies, and development of resistance during treatment.
J Antimicrob Chemother
; 78(4): 871-892, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36883356
3.
The primary pharmacology of ceftazidime/avibactam: in vitro translational biology.
J Antimicrob Chemother
; 77(9): 2321-2340, 2022 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35665807
4.
The primary pharmacology of ceftazidime/avibactam: in vivo translational biology and pharmacokinetics/pharmacodynamics (PK/PD).
J Antimicrob Chemother
; 77(9): 2341-2352, 2022 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35660869
5.
Selecting the dosage of ceftazidime-avibactam in the perfect storm of nosocomial pneumonia.
Eur J Clin Pharmacol
; 76(3): 349-361, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31836928
6.
Dose Selection and Validation for Ceftazidime-Avibactam in Adults with Complicated Intra-abdominal Infections, Complicated Urinary Tract Infections, and Nosocomial Pneumonia.
Antimicrob Agents Chemother
; 63(4)2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30670413
7.
Avibactam Pharmacokinetic/Pharmacodynamic Targets.
Antimicrob Agents Chemother
; 62(6)2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29610208
8.
Ceftazidime-Avibactam Susceptibility Breakpoints against Enterobacteriaceae and Pseudomonas aeruginosa.
Antimicrob Agents Chemother
; 62(11)2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30061279
9.
Selection of mutants with resistance or diminished susceptibility to ceftazidime/avibactam from ESBL- and AmpC-producing Enterobacteriaceae.
J Antimicrob Chemother
; 73(12): 3336-3345, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30247546
10.
A mathematical model-based analysis of the time-kill kinetics of ceftazidime/avibactam against Pseudomonas aeruginosa.
J Antimicrob Chemother
; 73(5): 1295-1304, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29415212
11.
Modeling the Kinetics of the Permeation of Antibacterial Agents into Growing Bacteria and Its Interplay with Efflux.
Antimicrob Agents Chemother
; 61(10)2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28717042
12.
AmpC ß-lactamase induction by avibactam and relebactam.
J Antimicrob Chemother
; 72(12): 3342-3348, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28962008
13.
Potentiation of ceftazidime by avibactam against ß-lactam-resistant Pseudomonas aeruginosa in an in vitro infection model.
J Antimicrob Chemother
; 72(4): 1109-1117, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28077672
14.
Distinctive Binding of Avibactam to Penicillin-Binding Proteins of Gram-Negative and Gram-Positive Bacteria.
Antimicrob Agents Chemother
; 60(2): 752-6, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26574008
15.
In Vitro Susceptibility of Global Surveillance Isolates of Pseudomonas aeruginosa to Ceftazidime-Avibactam (INFORM 2012 to 2014).
Antimicrob Agents Chemother
; 60(8): 4743-9, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27216074
16.
In Vitro Susceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014).
Antimicrob Agents Chemother
; 60(5): 3163-9, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26926648
17.
Pharmacodynamics of Ceftazidime and Avibactam in Neutropenic Mice with Thigh or Lung Infection.
Antimicrob Agents Chemother
; 60(1): 368-75, 2016 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26525790
18.
Structural and sequence analysis of class A ß-lactamases with respect to avibactam inhibition: impact of Ω-loop variations.
J Antimicrob Chemother
; 71(10): 2848-55, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27402011
19.
Role of the Outer Membrane and Porins in Susceptibility of ß-Lactamase-Producing Enterobacteriaceae to Ceftazidime-Avibactam.
Antimicrob Agents Chemother
; 60(3): 1349-59, 2015 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26666933
20.
In vitro selection of ceftazidime-avibactam resistance in Enterobacteriaceae with KPC-3 carbapenemase.
Antimicrob Agents Chemother
; 59(9): 5324-30, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26100712